Effective doses for strontium ranelate

Osteoporosis International

Volumn 19, Issue 12, 2008, Pages 1813-

  Marie, P J ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; STRONTIUM RANELATE; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MINERALIZATION; CALCIUM DEFICIENCY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; ESTROGEN DEFICIENCY; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; TREATMENT OUTCOME;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; THIOPHENES;

EID: 55049124913     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0740-x     Document Type: Letter

References (4)

1. RK Fuchs MR Allen KW Condon S Reinwald LM Miller D McClenathan B Keck RJ Phipps DB Burr 2008 Strontium ranelate does not stimulate bone formation in ovariectomized rats Osteoporos Int 19 1331 1341
2. PJ Meunier 2004 The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459 468
3. JY Reginster 2005 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2816 2822
4. PJ Marie 1993 An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J Bone Miner Res 8 607 615